Q3 venture financing rebounds
This article was originally published in Scrip
Venture capital investment into biotech drug discovery and development companies in the third quarter returned to historical levels following a strong September. The total amount of money put to work in the global sector during Q3 was about $1.46 billion. In the past five years, with the exception of 2009, biotech companies raised between $1.4 billion and $1.5 billion over the summer months. In 2009, the sector barely raised $1.1 billion.